Cells in the body have to move around in order to do their jobs. During development, for instance, cells are distributed to ...
Pharma giant Moderna (MRNA) is set to release its Q4 2024 results on February 14. MRNA stock has lost about 64% over the past ...
When Xiao Wang applied to faculty jobs, many of the institutions where she interviewed thought her research proposal - to ...
A complex molecular machine, the spliceosome, ensures that the genetic information from the genome, after being transcribed ...
A research team from POSTECH has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.
It's unclear how he will impact biotech stocks. Evaluate the expected performance of Moderna (MRNA) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom ...
In principle, mRNA vaccines are ideal for health emergencies as they can be quickly mass produced using a template. The problem is that current cell-based template production methods take too long, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results